Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin L Robb

Showing results (111-120 of 358) with videos related to

Pageof 36
Sort By:
JCI Insight|May 18, 2018
Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir sizeJeffrey E Teigler, Louise Leyre, Nicolas Chomont, et al.
Plos One|September 28, 2011
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cellsMichael A Eller, Bonnie M Slike, Josephine H Cox, et al.
Immunogenetics|April 1, 2014
HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trialHeather A Prentice, Philip K Ehrenberg, Karen M Baldwin, et al.
The Journal of Infectious Diseases|August 31, 2018
Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected KenyansAndrew Letizia, Michael A Eller, Christina Polyak, et al.
AIDS Research and Human Retroviruses|October 4, 2017
Intradermal HIV-1 DNA Immunization Using Needle-Free Zetajet Injection Followed by HIV-Modified Vaccinia Virus Ankara Vaccination Is Safe and Immunogenic in Mozambican Young Adults: A Phase I Randomized Controlled TrialEdna Omar Viegas, Nelson Tembe, Charlotta Nilsson, et al.
The Journal of Infectious Diseases|October 7, 2010
Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, TanzaniaRebecca N Koehler, Anne M Walsh, Elmar Saathoff, et al.
Frontiers in Immunology|May 16, 2020
Induction of Identical IgG HIV-1 Envelope Epitope Recognition Patterns After Initial HIVIS-DNA/MVA-CMDR Immunization and a Late MVA-CMDR BoostAgricola Joachim, Mohamed I M Ahmed, Georgios Pollakis, et al.
Nature Immunology|March 26, 2021
Multi-omics analyses reveal that HIV-1 alters CD4<sup>+</sup> T cell immunometabolism to fuel virus replicationHaitao Guo, Qi Wang, Khader Ghneim, et al.
Scientific Reports|April 23, 2017
A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infectionYufei Wang, Trevor Whittall, Stuart Neil, et al.
Virology|September 26, 2006
Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2Gustavo H Kijak, Sodsai Tovanabutra, Eric Sanders-Buell, et al.
Pageof 36

Showing results (111-120 of 358) with videos related to

Sort By:
Pageof 36
JCI Insight|May 18, 2018
Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir sizeJeffrey E Teigler, Louise Leyre, Nicolas Chomont, et al.
Plos One|September 28, 2011
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cellsMichael A Eller, Bonnie M Slike, Josephine H Cox, et al.
Immunogenetics|April 1, 2014
HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trialHeather A Prentice, Philip K Ehrenberg, Karen M Baldwin, et al.
The Journal of Infectious Diseases|August 31, 2018
Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected KenyansAndrew Letizia, Michael A Eller, Christina Polyak, et al.
AIDS Research and Human Retroviruses|October 4, 2017
Intradermal HIV-1 DNA Immunization Using Needle-Free Zetajet Injection Followed by HIV-Modified Vaccinia Virus Ankara Vaccination Is Safe and Immunogenic in Mozambican Young Adults: A Phase I Randomized Controlled TrialEdna Omar Viegas, Nelson Tembe, Charlotta Nilsson, et al.
The Journal of Infectious Diseases|October 7, 2010
Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, TanzaniaRebecca N Koehler, Anne M Walsh, Elmar Saathoff, et al.
Frontiers in Immunology|May 16, 2020
Induction of Identical IgG HIV-1 Envelope Epitope Recognition Patterns After Initial HIVIS-DNA/MVA-CMDR Immunization and a Late MVA-CMDR BoostAgricola Joachim, Mohamed I M Ahmed, Georgios Pollakis, et al.
Nature Immunology|March 26, 2021
Multi-omics analyses reveal that HIV-1 alters CD4<sup>+</sup> T cell immunometabolism to fuel virus replicationHaitao Guo, Qi Wang, Khader Ghneim, et al.
Scientific Reports|April 23, 2017
A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infectionYufei Wang, Trevor Whittall, Stuart Neil, et al.
Virology|September 26, 2006
Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2Gustavo H Kijak, Sodsai Tovanabutra, Eric Sanders-Buell, et al.
Pageof 36